<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230127057247N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-12</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of combined dietary supplementation of protein and creatine on outcomes in patients with peritrochanter fracture</public_title>
      <acronym>ERAS</acronym>
      <scientific_title>Effects of combined dietary supplementation of protein and creatine on outcomes and acceleration of postoperative recovery in patients with peritrochantic fracture: A double-blind interventional esoteric study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68400</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization with random numbers table, Blinding description: The supplement and placebo are blinded by the manufacturer in English letters and the patient, the executor, the researcher and the manufacturer are unaware of the complete collection of the fear and its data from receiving the supplement or placebo by the patient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Femoral neck fracture, intertroch fracture and subtroch of femoral fracture.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: including patients with pretrochanteric fractures (femoral neck, intertrochanteric and subtrochanteric) referred to Sina and Imam Khomeini Hospital in Tehran, after removing excluded cases according to the randomization table, they were divided into 2 groups. In the intervention group, after collecting demographic information and The request for tests includes cbc-crp-albumin-pre-albumin. Depending on the location and type of fracture and the clinical conditions, the patient is subjected to internal surgical fixation, and then after discharge for one month, a daily dose of 30 mg protein sachets dissolved in water, which includes He consumed creatinine, essential amino acids and protein, and after a month, the patient will be asked for the aforementioned tests and will be analyzed. Intervention 2: Control group:  including patients with peritrochanteric fractures (femoral neck, intertrochanteric and subtrochanteric) referring to Sina and Imam Khomeini Hospital in Tehran, after removing excluded cases, according to the randomization table, they were divided into 2 groups, in the control group, after collecting demographic information and Request for tests including cbc-crp-albumin-pre-albumin surgery depending on the location and type of fracture and the clinical conditions of the patient is subjected to internal surgical fixation and then after discharge for a month daily placebo protein sachets of 30 mg soluble in water which includes dextrose and after a month, the patient will be asked for the above-mentioned tests and will be analyzed. The table of the amount of starting the park before and after the surgery was completed for him in a comparative manner.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Reza Donyazad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>the end of Keshavarz Boulevard, Dr. Gharib Street; Imam Khomeini Hospital Complex (RA) - Orthopedic Department</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733141</zip>
        <telephone>+98 21 6697 0295</telephone>
        <email>dr.mrdonyazad@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Reza Donyazad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>the end of Keshavarz Boulevard, Dr. Gharib Street; Imam Khomeini Hospital Complex (RA) - Orthopedic Department</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733141</zip>
        <telephone>+98 21 6697 0295</telephone>
        <email>dr.mrdonyazad@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with Femur neck fracture or intertroch fracture or subtrochantric fracture</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Under 18 y/o
Pregnancy
Renal failure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S72.14</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Intertrochanteric fracture of femur</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: including patients with pretrochanteric fractures (femoral neck, intertrochanteric and subtrochanteric) referred to Sina and Imam Khomeini Hospital in Tehran, after removing excluded cases according to the randomization table, they were divided into 2 groups. In the intervention group, after collecting demographic information and The request for tests includes cbc-crp-albumin-pre-albumin. Depending on the location and type of fracture and the clinical conditions, the patient is subjected to internal surgical fixation, and then after discharge for one month, a daily dose of 30 mg protein sachets dissolved in water, which includes He consumed creatinine, essential amino acids and protein, and after a month, the patient will be asked for the aforementioned tests and will be analyzed.</i_keyword>
      <i_keyword>Control group:  including patients with peritrochanteric fractures (femoral neck, intertrochanteric and subtrochanteric) referring to Sina and Imam Khomeini Hospital in Tehran, after removing excluded cases, according to the randomization table, they were divided into 2 groups, in the control group, after collecting demographic information and Request for tests including cbc-crp-albumin-pre-albumin surgery depending on the location and type of fracture and the clinical conditions of the patient is subjected to internal surgical fixation and then after discharge for a month daily placebo protein sachets of 30 mg soluble in water which includes dextrose and after a month, the patient will be asked for the above-mentioned tests and will be analyzed. The table of the amount of starting the park before and after the surgery was completed for him in a comparative manner.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nutritional level by checking blood lymphocyte level changes. Timepoint: At the time of hospitalization and a month later. Method of measurement: Request for testing at the time of hospitalization and one month later.</prim_outcome>
      <prim_outcome>Nutritional level by checking changes in blood albumin level. Timepoint: At the time of hospitalization and a month later. Method of measurement: Request for testing at the time of hospitalization and one month later.</prim_outcome>
      <prim_outcome>Nutritional level by checking changes in blood CRP level. Timepoint: At the time of hospitalization and a month later. Method of measurement: Request for testing at the time of hospitalization and one month later.</prim_outcome>
      <prim_outcome>Changes in quality of life and the ability to perform daily activities and walk. Timepoint: At the time of hospitalization and a month later. Method of measurement: Parker questionnaire.</prim_outcome>
      <prim_outcome>30-day mortality. Timepoint: 30 days after surgery. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Time interval between hospitalization and surgery. Timepoint: Hospitalization day and surgery day. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Complications occurred for the patient including delirium and clinical venous thrombosis. Timepoint: In 30 days after surgery. Method of measurement: questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-23</approval_date>
        <contact_name>Tehran university of medical Science research committe ethics</contact_name>
        <contact_address>6th Floor, Central Building, Tehran University of Medical Sciences, Qods Street Intersection, Keshavarz Blvd. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
